FDA OKs Inhaled Levodopa (Inbrija) for Parkinson ' s ' Off ' Episodes FDA OKs Inhaled Levodopa (Inbrija) for Parkinson ' s ' Off ' Episodes

Levodopa inhalation powder aims to fill an unmet need for roughly 40% of patients with Parkinson ' s who experience off periods while taking an oral regimen of carbidopa-levodopa.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news